About Cabaletta Bio (CABA)
Cabaletta Bio Inc. is a clinical-stage biotechnology company. The Company is focused on discovery and development of engineered T-cell therapies for B cell-mediated autoimmune diseases. The T cells are designed to selectively bind and eliminate B cel... Read more
- USD1.30
- USD1.31
- USD1.23
- USD13.50
- -23.50%
- --
- 26.00
- 968.28k
- 56M
- 0.99
- -89.60%
Stock News
4 hours ago
VEU: A New Golden Age For International Equities
SeekingAlpha
4 hours ago
SIL: All That Glitters Is Not Gold, Sometimes It's Silver
SeekingAlpha
4 hours ago
Carnival Corporation: Stronger Fundamentals, Speculative Upside
SeekingAlpha
5 hours ago
Brookfield Renewable: Check Out That 6.9% Yield
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
